Study of a new medicine in healthy adults
Treatments studied
This study tests a new medicine in healthy volunteers to see how safe it is and how the body handles it. You will need to have had certain vaccines (meningitis and pneumonia) before joining, and you must be in generally good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old and in good general health.
- Weigh at least 50 kg if you are male or 45 kg if you are female, with a body mass index (BMI) between 19 and 28.
- You need to have received a recent meningitis vaccine (within the last 2 years) and a pneumonia vaccine (within a specific timeframe) before starting.
- You cannot have major heart, lung, liver, kidney, or blood diseases, and you must have normal blood tests.
- You must agree to use effective birth control during the study and for 3 months after the last dose.
- You cannot have any allergies to penicillin or vaccine ingredients, and you must not have used certain medications or vaccines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial is testing a new medicine called SSS55 in healthy adults to see if it is safe and how the body processes it. Participants will receive meningococcal and pneumococcal vaccines before the study.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. It is an early-phase trial, so it helps find the right dose and check for side effects.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.